Zou Yunlian, Zhang Jinping, Zhang Lichen, Yan Xinmin
Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China.
Institute of Medical Sciences, Yunnan Blood Disease Clinical Medical Center, The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650032, P.R. China.
Oncol Lett. 2021 Sep;22(3):687. doi: 10.3892/ol.2021.12948. Epub 2021 Jul 28.
Interferon-induced protein 16 (IFI16) is important for innate immune recognition of foreign/damaged DNA. Abnormal IFI16 expression is closely related to the occurrence of multiple malignant tumours, but its expression pattern in colorectal cancer (CRC) remains unclear. The present study aimed to investigated IFI16 expression and association with cell proliferation in CRC tissues and adjacent normal tissues. A multiplex immunofluorescence panel of antibodies against IFI16, Ki-67 and phosphorylated (p)-ERK1/2 was applied to assess a tissue microarray (TMA). The TMA included 77 CRC samples and 74 normal adjacent tissue samples which were collected from The First People's Hospital of Yunnan Province (Kunming, China) (3 paracancerous tissues were lost because of repeated cutting). Immunohistochemistry was used to detect CD8 tumour-infiltrating lymphocyte (TIL) abundance and programmed death-ligand 1 (PD-L1) expression in cancer tissues. The present study demonstrated that IFI16 localized to the nucleus of CRC cells. Although IFI16 was weakly expressed in normal mucosal epithelial cells, absent to strong expression was detectable in different patients with CRC. Typically, IFI16 was not co-localized with Ki-67 within CRC cells. The multiplex immunofluorescence data demonstrated that the proportion of IFI16/Ki-67 cells from CRC tissues was 57.13%; however, that of IFI16/Ki-67 cells was 1.50%. The IFI16/Ki-67 phenotype was significantly positively associated with the tumor-node-metastasis stage and was marginally significantly correlated with lymph node metastasis. p-ERK1/2 protein was primarily localized to the cytoplasm and cell membrane of CRC cells and sometimes to the nucleus. Although, IFI16 demonstrated a strong correlation with p-ERK1/2, IFI16 did not co-localize with p-ERK1/2 and the proportion of IFI16 and p-ERK1/2 double-negative CRC cells was 84.95%. IFI16 expression displayed no significant association with CD8 TILs or PD-L1. However, a strong positive correlation between CD8 TILs and PD-L1 was observed. High CD8 TIL infiltration in CRC tissue was associated with lower lymph node metastasis and tumor-node-metastasis stage. In summary, the results of the present study provided a novel insight for the role of IFI16 in CRC occurrence via the regulation of cancer cell proliferation.
干扰素诱导蛋白16(IFI16)对于对外源/损伤DNA的天然免疫识别很重要。IFI16表达异常与多种恶性肿瘤的发生密切相关,但其在结直肠癌(CRC)中的表达模式仍不清楚。本研究旨在调查CRC组织和相邻正常组织中IFI16的表达及其与细胞增殖的关系。应用针对IFI16、Ki-67和磷酸化(p)-ERK1/2的多重免疫荧光抗体组合来评估组织微阵列(TMA)。该TMA包含77个CRC样本和74个正常相邻组织样本,这些样本取自云南省第一人民医院(中国昆明)(3个癌旁组织因反复切割而丢失)。采用免疫组织化学法检测癌组织中CD8肿瘤浸润淋巴细胞(TIL)丰度和程序性死亡配体1(PD-L1)表达。本研究表明,IFI16定位于CRC细胞核。虽然IFI16在正常黏膜上皮细胞中弱表达,但在不同的CRC患者中可检测到从无表达到强表达的情况。通常,CRC细胞内IFI16不与Ki-67共定位。多重免疫荧光数据显示,CRC组织中IFI16/Ki-67细胞的比例为57.13%;然而,正常组织中IFI16/Ki-67细胞的比例为1.50%。IFI16/Ki-67表型与肿瘤-淋巴结-转移分期显著正相关,与淋巴结转移呈边缘显著相关。p-ERK1/2蛋白主要定位于CRC细胞的细胞质和细胞膜,有时也定位于细胞核。虽然IFI16与p-ERK1/2呈强相关,但IFI16不与p-ERK1/2共定位,IFI16和p-ERK1/2双阴性CRC细胞的比例为84.95%。IFI16表达与CD8 TILs或PD-L1无显著关联。然而,观察到CD8 TILs与PD-L1之间存在强正相关。CRC组织中高CD8 TIL浸润与较低的淋巴结转移和肿瘤-淋巴结-转移分期相关。总之,本研究结果为IFI16通过调节癌细胞增殖在CRC发生中的作用提供了新的见解。